Find Fish Oil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

68RELATED EXCIPIENT COMPANIES

118EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

KDMF

read-more
read-moreread-more

01

Chemport Inc

United Kingdom
PEGS Boston Summit
Not Confirmed
arrow

Chemport Inc

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : Chemport Co., Ltd.

Registration Date : 2015-12-08

Registration Number : 3-1-ND

Manufacturer Name : Chemport Co., Ltd.

Manufacturer Address : (58275) 30-51 Dongsunonggongdanji-gil, Naju-si, Jeollanam-do

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : Fresenius Kabi Korea Co., Ltd.

Registration Date : 2006-03-02

Registration Number : Su-31-ND

Manufacturer Name : Fresenius Kabi AB

Manufacturer Address : Rapsgatan 7 SE-751 74 Uppsala SWEDEN

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : Fresenius Kabi Korea Co., Ltd.

Registration Date : 2016-03-04

Registration Number : Su4238-2-ND

Manufacturer Name : Fresenius Kabi Deutschland G...

Manufacturer Address : Werk Friedberg Pfingstweide 53, D-61169 Friedberg, Germany

blank

04

Lipoid GMBH

Germany
PEGS Boston Summit
Not Confirmed
arrow

Lipoid GMBH

Germany
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : WiseMedi Co., Ltd.

Registration Date : 2014-10-15

Registration Number : Number 4786-1-ND(2)

Manufacturer Name : Lipoid GmbH

Manufacturer Address : Frigenstrasse 4, D-67065 Ludwigshafen, Federal Republic of Germany

blank

05

Lipoid GMBH

Germany
PEGS Boston Summit
Not Confirmed
arrow

Lipoid GMBH

Germany
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : JW Life Science Co., Ltd.

Registration Date : 2013-09-27

Registration Number : Number 4786-1-ND

Manufacturer Name : Lipoid GmbH

Manufacturer Address : Frigenstrasse 4, D-67065 Ludwigshafen, Federal Republic of Germany

blank

06

Lipoid GMBH

Germany
PEGS Boston Summit
Not Confirmed
arrow

Lipoid GMBH

Germany
arrow
PEGS Boston Summit
Not Confirmed

refined fish oil

Registrant Name : HK Innoen Co., Ltd.

Registration Date : 2014-05-13

Registration Number : Number 4786-1-ND(1)

Manufacturer Name : Lipoid GmbH

Manufacturer Address : Frigenstrasse 4, D-67065 Ludwigshafen, Federal Republic of Germany

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBasic Nutrition, your expert for sourcing from China, India and Europe.

Flag China
Digital Content Digital Content

Fish Oil

About the Company : As an ISO9001, ISO22000 certificated supplier, Basic Nutrition supply high-quality ingredients for nutraceuticals. We can offer a range of products from small to large quantites: h...

As an ISO9001, ISO22000 certificated supplier, Basic Nutrition supply high-quality ingredients for nutraceuticals. We can offer a range of products from small to large quantites: herbal extract, amino acid, vitamin, etc. Featured products: cranberry extract, rhidiola extract, Q10, hyaluronic acid, cysteine (non-animals), glutathoninr, orgaic products like organic spirulina, organic red yeast rice powder, etc.
Basic Nutrition Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Fish Oil is a dietary supplement drug, which is currently being evaluated in clinical studies for the treatment of undisclosed medical condition.


Lead Product(s): Fish Oil,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Omegaquant Analytics, LLC

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 18, 2026

blank

01

Fatty Acid Research Institute

Country
arrow
PEGS Boston Summit
Not Confirmed

Fatty Acid Research Institute

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fish Oil,Inapplicable

Therapeutic Area : Undisclosed

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Omegaquant Analytics, LLC

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a dietary supplement drug, which is currently being evaluated in clinical studies for the treatment of undisclosed medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

March 18, 2026

blank
  • Development Update

Details:

Salmon oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Supplementation in Healthy Adults.


Lead Product(s): Omega-3,Fish Oil

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 30, 2025

blank

02

Hofseth Biocare ASA

Country
arrow
PEGS Boston Summit
Not Confirmed

Hofseth Biocare ASA

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Salmon oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Supplementation in Healthy Adults.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

January 30, 2025

blank

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Fish Oil,Icosapent Ethyl,L-5- Methyltetrahydrofolate

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Glogen Clinical Research Pvt. Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 06, 2025

blank

03

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fish Oil,Icosapent Ethyl,L-5- Methyltetrahydrofolate

Therapeutic Area : Undisclosed

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Glogen Clinical Research Pvt. Ltd

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

January 06, 2025

blank

Details:

Omega 1035DS is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.


Lead Product(s): Omega 1035DS,Omega O3020DS,Fish Oil

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 08, 2024

blank

04

RDC Clinical

Australia
arrow
PEGS Boston Summit
Not Confirmed

RDC Clinical

Australia
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Omega 1035DS,Omega O3020DS,Fish Oil

Therapeutic Area : Undisclosed

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Omega 1035DS is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

October 08, 2024

blank
  • Development Update

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Fish Oil,Wild Orange Essential Oil Supplement

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 09, 2024

blank

05

dōTERRA International

Country
arrow
PEGS Boston Summit
Not Confirmed

dōTERRA International

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fish Oil,Wild Orange Essential Oil Supplement

Therapeutic Area : Undisclosed

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

July 09, 2024

blank
  • Development Update

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.


Lead Product(s): Fish Oil,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Dietary Supplement

Sponsor: University Hospital, Bonn | University Hospital Muenster | University Hospital Göttingen | University Hospital Schleswig-Holstein | Charite University, Berlin, Germany | Wuerzburg University Hospital | Johannes Gutenberg University Mainz | University Hosp

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 28, 2024

blank

06

GCP-Service International

Country
arrow
PEGS Boston Summit
Not Confirmed

GCP-Service International

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fish Oil,Inapplicable

Therapeutic Area : Undisclosed

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : University Hospital, Bonn | University Hospital Muenster | University Hospital Göttingen | University Hospital Schleswig-Holstein | Charite University, Berlin, Germany | Wuerzburg University Hospital | Johannes Gutenberg University Mainz | University Hosp

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

February 28, 2024

blank
  • Development Update

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Depression.


Lead Product(s): Fish Oil,Probiotic

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase II/ Phase IIIProduct Type: Dietary Supplement

Sponsor: Sunnybrook Health Sciences Centre | Lotte & John Hecht Memorial Foundation

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 10, 2023

blank

07

Canadian College of Naturopathic Medicine

Country
arrow
PEGS Boston Summit
Not Confirmed

Canadian College of Naturopathic Medicine

Country
arrow
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Fish Oil,Probiotic

Therapeutic Area : Psychiatry/Psychology

Highest Development Status : Phase II/ Phase III

Partner/Sponsor/Collaborator : Sunnybrook Health Sciences Centre | Lotte & John Hecht Memorial Foundation

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Depression.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

October 10, 2023

blank

Details:

Omega-3 Fatty Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Omega-3 Fatty Acid,Fish Oil

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: BioTeSys GmbH

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 14, 2022

blank

08

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Lead Product(s) : Omega-3 Fatty Acid,Fish Oil

Therapeutic Area : Undisclosed

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : BioTeSys GmbH

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Omega-3 Fatty Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 14, 2022

blank
  • Development Update

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition.


Lead Product(s): Fish Oil,Lutein,Zeaxanthin,Vitamin D

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: True Eye Experts - New Tampa

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 09, 2022

blank

09

Applied Science & Performance Institute

Country
arrow
PEGS Boston Summit
Not Confirmed

Applied Science & Performance Institute

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

September 09, 2022

blank
  • Development Update

Details:

Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Fish Oil,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Dietary Supplement

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 16, 2022

blank

10

Marinex International Sp. z o.o.

Country
arrow
PEGS Boston Summit
Not Confirmed

Marinex International Sp. z o.o.

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Fish Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Dietary Supplement

Upfront Cash : Inapplicable

August 16, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Zinc Oxide; Cod Liver Oil

Brand Name : Carena

Dosage Form : Ointment

Dosage Strength : 5MG; 270 MG

Packaging :

Approval Date : 01-12-1960

Application Number : 35090

Regulatory Info : Cancelled

Registration Country : Spain

Sanofi Company Banner

02

Bahrain Pharma

Bahrain
PEGS Boston Summit
Not Confirmed
arrow

Bahrain Pharma

Bahrain
arrow
PEGS Boston Summit
Not Confirmed

Fish oil; Vitamin E

Brand Name : Feom-3

Dosage Form : CAPSULE

Dosage Strength : 1000MG; 1IU

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Bahrain

blank

03

Bahrain Pharma

Bahrain
PEGS Boston Summit
Not Confirmed
arrow

Bahrain Pharma

Bahrain
arrow
PEGS Boston Summit
Not Confirmed

Fish oil

Brand Name : Olifix

Dosage Form : CAPSULE

Dosage Strength : 1000MG

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Bahrain

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Cod Liver Oil

Brand Name :

Dosage Form : Capsule

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (100ML)

Packaging :

Approval Date : 2016-07-13

Application Number : 207648

Regulatory Info : RX

Registration Country : USA

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (250ML)

Packaging :

Approval Date : 2016-07-13

Application Number : 207648

Regulatory Info : RX

Registration Country : USA

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (500ML)

Packaging :

Approval Date : 2016-07-13

Application Number : 207648

Regulatory Info : RX

Registration Country : USA

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (1000ML)

Packaging :

Approval Date : 2018-08-10

Application Number : 207648

Regulatory Info : RX

Registration Country : USA

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL TRIGLYCERIDES

Brand Name : OMEGAVEN

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 5GM/50ML (0.1GM/ML)

Packaging :

Approval Date : 2018-07-27

Application Number : 210589

Regulatory Info : RX

Registration Country : USA

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL TRIGLYCERIDES

Brand Name : OMEGAVEN

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 10GM/100ML (0.1GM/ML)

Packaging :

Approval Date : 2018-07-27

Application Number : 210589

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (100ML)

Approval Date : 2016-07-13

Application Number : 207648

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (250ML)

Approval Date : 2016-07-13

Application Number : 207648

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (500ML)

Approval Date : 2016-07-13

Application Number : 207648

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL

Brand Name : SMOFLIPID 20%

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (1000ML)

Approval Date : 2018-08-10

Application Number : 207648

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL TRIGLYCERIDES

Brand Name : OMEGAVEN

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 5GM/50ML (0.1GM/ML)

Approval Date : 2018-07-27

Application Number : 210589

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

FISH OIL TRIGLYCERIDES

Brand Name : OMEGAVEN

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 10GM/100ML (0.1GM/ML)

Approval Date : 2018-07-27

Application Number : 210589

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Zinc Oxide; Cod Liver Oil

Brand Name : Carena

Dosage Form : Ointment

Dosage Strength : 5MG; 270 MG

Packaging :

Approval Date : 01-12-1960

Application Number : 35090

Regulatory Info : Cancelled

Registration Country : Spain

Sanofi Company Banner

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Serine; Glucose Monohydrate; Potassium Chloride; Phenylalanine; Tryptophan; Glycine; Histidine; Isoleucine; Leucine; Threonine; Methionine; Calcium Chloride Dihydrate; Magnesium Sulfate Heptahydrate; Proline; Sodium Acetate Trihydrate; Lysine Acetate; Valine; Alanine; Tyrosine; Arginine; Taurine; Medium Chain Triglycerides; Zinc Sulfate Heptahydrate; Soybean; Refined Olive Oil; Refined Fish Oil Rich In Omega 3; Sodium Glycerophosphate Hydrated

Brand Name : Smofkabiven Low Osmo Peripheral Emulsion For Infusion

Dosage Form : Emulsion For Infusion

Dosage Strength :

Packaging :

Approval Date : 15-01-2019

Application Number : 83767

Regulatory Info : Authorized

Registration Country : Spain

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Serine; Glucose Monohydrate; Potassium Chloride; Phenylalanine; Tryptophan; Glycine; Histidine; Isoleucine; Leucine; Threonine; Methionine; Calcium Chloride Dihydrate; Magnesium Sulfate Heptahydrate; Proline; Sodium Acetate Trihydrate; Lysine Acetate; Valine; Alanine; Sodium Glycerophosphate; Tyrosine; Arginine; Taurine; Medium Chain Triglycerides; Zinc Sulfate Heptahydrate; Soybean; Refined Olive Oil; Refined Fish Oil Rich In Omega 3

Brand Name : Smofkabiven Extra Nitrogen Emulsion For Infusion

Dosage Form : Emulsion For Infusion

Dosage Strength :

Packaging :

Approval Date : 14-12-2017

Application Number : 82509

Regulatory Info : Authorized

Registration Country : Spain

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Serine; Glucose Monohydrate; Potassium Chloride; Purified Soybean Oil; Phenylalanine; Olive Oil; L-Tryptophan; Glycine; Histidine; Isoleucine; Leucine; Threonine; Methionine; Calcium Chloride Dihydrate; Magnesium Sulfate Heptahydrate; Proline; Sodium Acetate Trihydrate; Lysine Acetate; Valine; Alanine; Sodium Glycerophosphate; Tyrosine; Arginine; Taurine; Medium Chain Triglycerides; Fish Oil; Zinc Sulfate Heptahydrate

Brand Name : Smofkabiven Central Emulsion For Infusion

Dosage Form : Emulsion For Infusion

Dosage Strength :

Packaging :

Approval Date : 06-05-2009

Application Number : 70895

Regulatory Info : Authorized

Registration Country : Spain

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Serine; Glucose Monohydrate; Potassium Chloride; Purified Soybean Oil; Phenylalanine; Olive Oil; Tryptophan; Glycine; Histidine; Isoleucine; Leucine; Threonine; Methionine; Calcium Chloride Dihydrate; Magnesium Sulfate Heptahydrate; Proline; Sodium Acetate Trihydrate; Lysine Acetate; Valine; Alanine; Sodium Glycerophosphate; Tyrosine; Arginine; Taurine; Medium Chain Triglycerides; Fish Oil; Zinc Sulfate Heptahydrate

Brand Name : Smofkabiven Peripheral Emulsion For Infusion

Dosage Form : Emulsion For Infusion

Dosage Strength :

Packaging :

Approval Date : 31-07-2009

Application Number : 70513

Regulatory Info : Authorized

Registration Country : Spain

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fish Oil; Rich In Omega-3 Acids; Olive Oil; Refined; Soybean Oil; Triglycerides; Medium Chain Length

Brand Name : Smoflipid

Dosage Form : Infusion Solution

Dosage Strength : 200mg/ml

Packaging :

Approval Date : 21-09-2004

Application Number : 28103647904

Regulatory Info : Prescription

Registration Country : Denmark

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fish Oil (Omega-3 fatty acids); Glycerol; Purified Egg Phospholipids

Brand Name : Omegaven

Dosage Form : Infusion Emulsion

Dosage Strength :

Packaging :

Approval Date : 18-12-1998

Application Number : 2.00E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fish Oil (Omega-3 fatty acids); Olive Oil; Refined Soybean Oil; Medium-Chain Triglycerides

Brand Name : Smoflipid

Dosage Form : Infusion Emulsion

Dosage Strength : 200mg/ml

Packaging :

Approval Date : 06-02-2004

Application Number : 2.00E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Fish Oil (Omega-3 fatty acids); Olive Oil; Refined Soybean Oil; Medium-Chain Triglycerides

Brand Name : Optilipid

Dosage Form : Infusion Emulsion

Dosage Strength : 200mg/ml

Packaging :

Approval Date : 08-04-2005

Application Number : 2.00E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Refined Soybean Oil; Medium-Chain Triglycerides; Refined Olive Oil; Fish Oil

Brand Name : SMOFlipid

Dosage Form : Emulsion For Infusion

Dosage Strength :

Packaging :

Approval Date : 20/07/2006

Application Number : 57231

Regulatory Info : Allowed

Registration Country : Switzerland

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM...DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (1000ML)

USFDA APPLICATION NUMBER - 207648

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM...DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (100ML)

USFDA APPLICATION NUMBER - 207648

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM...DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (250ML)

USFDA APPLICATION NUMBER - 207648

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM...DOSAGE - EMULSION;INTRAVENOUS - 3GM/100ML;6GM/100ML;5GM/100ML;6GM/100ML (500ML)

USFDA APPLICATION NUMBER - 207648

read-more

DOSAGE - EMULSION;INTRAVENOUS - 10GM/100ML (0...DOSAGE - EMULSION;INTRAVENOUS - 10GM/100ML (0.1GM/ML)

USFDA APPLICATION NUMBER - 210589

read-more

DOSAGE - EMULSION;INTRAVENOUS - 5GM/50ML (0.1...DOSAGE - EMULSION;INTRAVENOUS - 5GM/50ML (0.1GM/ML)

USFDA APPLICATION NUMBER - 210589

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Empty Capsules

read-more
read-more

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Direct Compression

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Granulation

read-more
read-more

Rheology Modifiers

read-more
read-more

Soft Gelatin

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty